About
CardiaCare is a clinical stage Digital Therapeutic company has developed the world’s first closed loop wearable for non-invasive treatment of Atrial Fibrillation and other cardiac arrhythmias. Providing a non-invasive, nerve stimulation treatment with continuous monitoring and AI based alerts capabilities, CardiaCare’s device is the only platform that enables complete remote patient management and personalized treatment.
The device stems from many years of treatment of real-world patients and integrates know how and innovation from diverse disciplines. CardiaCare has a functional prototype and successfully completed a FIM study. Multi-National RCT's are currently underway.
Funding history · 4 rounds · $4.3M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was CardiaCare founded?
- CardiaCare was founded in January 2015.
- What is CardiaCare's primary focus?
- CardiaCare focuses on developing a closed-loop wearable for non-invasive treatment of Atrial Fibrillation and other cardiac arrhythmias.
- How much funding has CardiaCare raised in total?
- CardiaCare has raised a total of $4,330,000 across multiple seed rounds. For a full financing history, please refer to startupim.
- Which investor participated in CardiaCare's Seed round in July 2018?
- Solardis Health Ventures participated in CardiaCare's Seed round in July 2018.
- What is the current employee count for CardiaCare?
- CardiaCare currently has 11 employees.
- What is CardiaCare's current funding stage?
- CardiaCare is currently in its Series A funding stage, with the latest round announced for July 2025.
- When did CardiaCare complete a Seed Extension raise to support clinical pilot studies?
- CardiaCare completed a Seed Extension raise to support clinical pilot studies in September 2023.
- When did CardiaCare announce a licensing and distribution agreement for its digital neuromodulation wearable?
- CardiaCare announced a licensing and distribution agreement to commercialize its digital neuromodulation wearable for non-invasive atrial fibrillation treatment in December 2022.
- Who was named as the chair of CardiaCare's board in May 2023?
- Ken Nelson was named as the chair of CardiaCare's board in May 2023.
- What award did CardiaCare receive in December 2019?
- CardiaCare was awarded First Prize at the Innovation in Cardiovascular Interventions (ICI) Technology Parade in Tel Aviv, Israel, in December 2019.